Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-11-30
1994-12-27
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514181, 514182, A61K 31575
Patent
active
053766520
ABSTRACT:
A method for preventing or reducing restenosis wherein a 27-hydroxycholesterol or a 25,26 and/or 27-aminocholesterol, or a sterol 27-hydroxylase stimulant is administered in a restenosis preventing and/or reducing amount.
REFERENCES:
patent: 4427688 (1984-01-01), Javitt
patent: 4939134 (1990-07-01), Javitt et al.
Zhou, et al., Proc. Soc. Exp. Biol. Exp. Biol. Med., 202:75-80 (1993).
Nassem, et al., Biochem. Internat., 14:71-84 (1987).
Baranowski, et al., Atherosclerosis, 41:255-260 (1982).
Kandutsch, et al., Science, 201, 498 (1978).
DeCaprio, et al., Journal of Lipid Research, vol. 33, pp. 441-443 (1992).
Hydorn Michael B.
New York University Medical Center
Richter Johann
LandOfFree
Administration of a 27-hydroxycholesterol or related compound or does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of a 27-hydroxycholesterol or related compound or, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of a 27-hydroxycholesterol or related compound or will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-919904